Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii
Open Access
- 30 September 2024
- journal article
- research article
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 10 (1) , 1-13
Abstract
Acinetobacter baumannii is designated by the World Health Organisation as a critical priority pathogen. Previously we discovered antimicrobial peptides (AMPs), namely Lynronne-1, -2 and -3, with efficacy against bacterial pathogens, such as Staphylococcus aureus and Pseudomonas aeruginosa. Here we assessed Lynronne-1, -2 and -3 structure by circular dichroism and efficacy against clinical strains of A. baumannii. All Lynronne AMPs demonstrated alpha-helical secondary structures and had antimicrobial activity towards all tested strains of A. baumannii (Minimum Inhibitory Concentrations 2–128 μg/ml), whilst also having anti-biofilm activity. Lynronne-2 and -3 demonstrated additive effects with amoxicillin and erythromycin, and synergy with gentamicin. The AMPs demonstrated little toxicity towards mammalian cell lines or Galleria mellonella. Fluorescence-based assay data demonstrated that Lynronne-1 and -3 had higher membrane-destabilising action against A. baumannii in comparison with Lynronne-2, which was corroborated by transcriptomic analysis. For the first time, we demonstrate the therapeutic activity of Lynronne AMPs against A. baumannii.Keywords
This publication has 59 references indexed in Scilit:
- Trehalose Metabolism: From Osmoprotection to SignalingInternational Journal of Molecular Sciences, 2009
- Quinolone-Mediated Bacterial DeathAntimicrobial Agents and Chemotherapy, 2008
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3Peptides, 2008
- Using circular dichroism spectra to estimate protein secondary structureNature Protocols, 2006
- How to study proteins by circular dichroismBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimensJournal of Antimicrobial Chemotherapy, 2004
- Mechanisms of Antimicrobial Peptide Action and ResistancePharmacological Reviews, 2003
- Antimicrobial peptides of multicellular organismsNature, 2002
- A Set of Constructed Type Spectra for the Practical Estimation of Peptide Secondary Structure from Circular DichroismAnalytical Biochemistry, 1997